• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有多少未被发现?现场人类疟原虫分子检测的概率。

How much remains undetected? Probability of molecular detection of human Plasmodia in the field.

机构信息

Swiss Tropical and Public Health Institute, Basel, Switzerland.

出版信息

PLoS One. 2011 Apr 28;6(4):e19010. doi: 10.1371/journal.pone.0019010.

DOI:10.1371/journal.pone.0019010
PMID:21552561
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3084249/
Abstract

BACKGROUND

In malaria endemic areas, most people are simultaneously infected with different parasite clones. Detection of individual clones is hampered when their densities fluctuate around the detection limit and, in case of P. falciparum, by sequestration during part of their life cycle. This has important implications for measures of levels of infection or for the outcome of clinical trials. This study aimed at measuring the detectability of individual P. falciparum and P. vivax parasite clones in consecutive samples of the same patient and at investigating the impact of sampling strategies on basic epidemiological measures such as multiplicity of infection (MOI).

METHODS

Samples were obtained in a repeated cross-sectional field survey in 1 to 4.5 years old children from Papua New Guinea, who were followed up in 2-monthly intervals over 16 months. At each follow-up visit, two consecutive blood samples were collected from each child at intervals of 24 hours. Samples were genotyped for the polymorphic markers msp2 for P. falciparum and msp1F3 and MS16 for P. vivax. Observed prevalence and mean MOI estimated from single samples per host were compared to combined data from sampling twice within 24 h.

FINDINGS AND CONCLUSION

Estimated detectability was high in our data set (0.79 [95% CI 0.76-0.82] for P. falciparum and, depending on the marker, 0.61 [0.58-0.63] or 0.73 [0.71-0.75] for P. vivax). When genotyping data from sequential samples, collected 24 hours apart, were combined, the increase in measured prevalence was moderate, 6 to 9% of all infections were missed on a single day. The effect on observed MOI was more pronounced, 18 to 31% of all individual clones were not detected in a single bleed. Repeated sampling revealed little difference between detectability of P. falciparum and P. vivax.

摘要

背景

在疟疾流行地区,大多数人同时感染不同的寄生虫克隆。当它们的密度在检测限附近波动时,以及在疟原虫生命周期的一部分被隔离时,检测单个克隆就会受到阻碍。这对感染水平的测量或临床试验的结果都有重要影响。本研究旨在测量同一患者连续样本中单个疟原虫和间日疟原虫寄生虫克隆的可检测性,并研究采样策略对基本流行病学指标(如感染多重性)的影响。

方法

在巴布亚新几内亚 1 至 4.5 岁儿童中进行了一项重复的横断面现场调查,这些儿童在 16 个月的时间里每两个月随访一次。在每次随访时,每个孩子都在 24 小时的间隔内采集两份连续的血液样本。对样本进行了疟原虫多态性标记物 msp2 和 msp1F3 以及间日疟原虫 MS16 的基因分型。观察到的患病率和从单个样本估计的平均 MOI 与 24 小时内两次采样的组合数据进行了比较。

发现和结论

在我们的数据集中,估计的可检测性很高(0.79[95%置信区间 0.76-0.82]为疟原虫,取决于标记物,0.61[0.58-0.63]或 0.73[0.71-0.75]为间日疟原虫)。当在 24 小时的间隔内收集的连续样本的基因分型数据结合在一起时,测量到的患病率略有增加,在一天内会错过所有感染的 6-9%。对观察到的 MOI 的影响更为明显,在单次采血中未检测到所有个体克隆的 18-31%。重复采样发现疟原虫和间日疟原虫的可检测性之间几乎没有差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6b4/3084249/1d21d940e244/pone.0019010.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6b4/3084249/572702e56817/pone.0019010.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6b4/3084249/2f244456219e/pone.0019010.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6b4/3084249/914a7fb241c1/pone.0019010.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6b4/3084249/dd17ccff829d/pone.0019010.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6b4/3084249/1d21d940e244/pone.0019010.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6b4/3084249/572702e56817/pone.0019010.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6b4/3084249/2f244456219e/pone.0019010.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6b4/3084249/914a7fb241c1/pone.0019010.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6b4/3084249/dd17ccff829d/pone.0019010.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6b4/3084249/1d21d940e244/pone.0019010.g005.jpg

相似文献

1
How much remains undetected? Probability of molecular detection of human Plasmodia in the field.有多少未被发现?现场人类疟原虫分子检测的概率。
PLoS One. 2011 Apr 28;6(4):e19010. doi: 10.1371/journal.pone.0019010.
2
The Incidence and Differential Seasonal Patterns of Plasmodium vivax Primary Infections and Relapses in a Cohort of Children in Papua New Guinea.巴布亚新几内亚一组儿童中间日疟原虫初次感染和复发的发病率及季节性差异模式
PLoS Negl Trop Dis. 2016 May 4;10(5):e0004582. doi: 10.1371/journal.pntd.0004582. eCollection 2016 May.
3
Multiplicity and diversity of Plasmodium vivax infections in a highly endemic region in Papua New Guinea.在巴布亚新几内亚高度流行地区,间日疟原虫感染的多发性和多样性。
PLoS Negl Trop Dis. 2011 Dec;5(12):e1424. doi: 10.1371/journal.pntd.0001424. Epub 2011 Dec 20.
4
Differential patterns of infection and disease with P. falciparum and P. vivax in young Papua New Guinean children.在年轻的巴布亚新几内亚儿童中,疟原虫和疟原虫的感染和疾病模式存在差异。
PLoS One. 2010 Feb 4;5(2):e9047. doi: 10.1371/journal.pone.0009047.
5
A large proportion of asymptomatic Plasmodium infections with low and sub-microscopic parasite densities in the low transmission setting of Temotu Province, Solomon Islands: challenges for malaria diagnostics in an elimination setting.在所罗门群岛的低传播环境下,在坦莫图省存在大量无症状且寄生虫密度低和亚显微的疟原虫感染:消除环境下疟疾诊断的挑战。
Malar J. 2010 Sep 7;9:254. doi: 10.1186/1475-2875-9-254.
6
High Rates of Asymptomatic, Sub-microscopic Plasmodium vivax Infection and Disappearing Plasmodium falciparum Malaria in an Area of Low Transmission in Solomon Islands.所罗门群岛低传播地区无症状、亚显微间日疟原虫感染率高以及恶性疟原虫疟疾消失
PLoS Negl Trop Dis. 2015 May 21;9(5):e0003758. doi: 10.1371/journal.pntd.0003758. eCollection 2015 May.
7
Significant geographical differences in prevalence of mutations associated with Plasmodium falciparum and Plasmodium vivax drug resistance in two regions from Papua New Guinea.巴布亚新几内亚两个地区与恶性疟原虫和间日疟原虫耐药性相关的突变流行率存在显著地理差异。
Malar J. 2015 Oct 9;14:399. doi: 10.1186/s12936-015-0879-9.
8
Implementation of a novel PCR based method for detecting malaria parasites from naturally infected mosquitoes in Papua New Guinea.在巴布亚新几内亚实施一种基于新型聚合酶链式反应的方法,用于检测自然感染疟原虫的蚊子。
Malar J. 2009 Aug 1;8:182. doi: 10.1186/1475-2875-8-182.
9
The shape of the iceberg: quantification of submicroscopic Plasmodium falciparum and Plasmodium vivax parasitaemia and gametocytaemia in five low endemic settings in Ethiopia.冰山一角:埃塞俄比亚五个低疟疾流行地区亚显微恶性疟原虫和间日疟原虫血症及配子体血症的定量分析
Malar J. 2017 Mar 3;16(1):99. doi: 10.1186/s12936-017-1749-4.
10
Multiplicity and molecular epidemiology of Plasmodium vivax and Plasmodium falciparum infections in East Africa.东非地区间日疟原虫和恶性疟原虫感染的多发性和分子流行病学。
Malar J. 2018 May 2;17(1):185. doi: 10.1186/s12936-018-2337-y.

引用本文的文献

1
Bridging the Gap from Molecular Surveillance to Programmatic Decisions for Malaria Control and Elimination.弥合从疟疾监测到疟疾控制与消除规划决策之间的差距。
Am J Trop Med Hyg. 2023 Dec 26;112(1_Suppl):35-47. doi: 10.4269/ajtmh.22-0749. Print 2025 Jan 7.
2
Prevalence and force of Plasmodium vivax blood-stage infection and associated clinical malaria burden in the Brazilian Amazon.巴西亚马逊地区间日疟原虫血期感染的流行率和强度及其相关临床疟疾负担。
Mem Inst Oswaldo Cruz. 2022 Jun 24;117:e210330. doi: 10.1590/0074-02760210330. eCollection 2022.
3
A Cohort Study on the Duration of Plasmodium falciparum Infections During the Dry Season in The Gambia.

本文引用的文献

1
Detectability of Plasmodium falciparum clones.恶性疟原虫克隆的检测能力。
Malar J. 2010 Aug 18;9:234. doi: 10.1186/1475-2875-9-234.
2
The international limits and population at risk of Plasmodium vivax transmission in 2009.2009 年按蚊传播间日疟原虫的国际界限和危险人群。
PLoS Negl Trop Dis. 2010 Aug 3;4(8):e774. doi: 10.1371/journal.pntd.0000774.
3
On the cytoadhesion of Plasmodium vivax-infected erythrocytes.关于感染疟原虫 vivax 的红细胞的细胞黏附。
冈比亚旱季期间恶性疟原虫感染持续时间的队列研究。
J Infect Dis. 2022 Aug 12;226(1):128-137. doi: 10.1093/infdis/jiac116.
4
Improved Detectability of Plasmodium falciparum Clones with Repeated Sampling in Incident and Chronic Infections in Burkina Faso.在布基纳法索的现症和慢性感染中,重复采样提高了恶性疟原虫克隆的检出率。
Am J Trop Med Hyg. 2021 Nov 1;106(2):664-666. doi: 10.4269/ajtmh.21-0493.
5
Systematic review of Plasmodium falciparum and Plasmodium vivax polyclonal infections: Impact of prevalence, study population characteristics, and laboratory procedures.疟原虫(Plasmodium falciparum 和 Plasmodium vivax)混合感染的系统评价:流行率、研究人群特征和实验室程序的影响。
PLoS One. 2021 Jun 11;16(6):e0249382. doi: 10.1371/journal.pone.0249382. eCollection 2021.
6
Gametocyte carriage of Plasmodium falciparum (pfs25) and Plasmodium vivax (pvs25) during mass screening and treatment in West Timor, Indonesia: a longitudinal prospective study.在印度尼西亚西帝汶进行大规模筛查和治疗期间,恶性疟原虫(pfs25)和间日疟原虫(pvs25)配子体的携带情况:一项纵向前瞻性研究。
Malar J. 2021 Apr 9;20(1):177. doi: 10.1186/s12936-021-03709-y.
7
Development of a new barcode-based, multiplex-PCR, next-generation-sequencing assay and data processing and analytical pipeline for multiplicity of infection detection of Plasmodium falciparum.开发一种新的基于条码的多重聚合酶链反应-下一代测序检测方法,以及数据处理和分析流程,用于检测疟原虫感染的多重性。
Malar J. 2021 Feb 16;20(1):92. doi: 10.1186/s12936-021-03624-2.
8
Persistence of mRNA indicative of Plasmodium falciparum ring-stage parasites 42 days after artemisinin and non-artemisinin combination therapy in naturally infected Malians.在自然感染的马里人中,青蒿素和非青蒿素联合疗法后 42 天,mRNA 持续存在表明恶性疟原虫环状体寄生虫存在。
Malar J. 2021 Jan 9;20(1):34. doi: 10.1186/s12936-020-03576-z.
9
Sex-based differences in clearance of chronic infection.基于性别的慢性感染清除差异。
Elife. 2020 Oct 27;9:e59872. doi: 10.7554/eLife.59872.
10
Differential impact of malaria control interventions on P. falciparum and P. vivax infections in young Papua New Guinean children.疟疾控制干预措施对巴布亚新几内亚儿童中恶性疟原虫和间日疟原虫感染的差异影响。
BMC Med. 2019 Dec 9;17(1):220. doi: 10.1186/s12916-019-1456-9.
J Infect Dis. 2010 Aug 15;202(4):638-47. doi: 10.1086/654815.
4
Fever, malaria and primary repetition rates amongst school children in Mali: combining demographic and health surveys (DHS) with spatial malariological measures.马里学童中的发热、疟疾和初次复发率:将人口与健康调查(DHS)与空间疟疾学措施相结合。
Soc Sci Med. 2010 Jul;71(2):314-323. doi: 10.1016/j.socscimed.2010.03.034. Epub 2010 Apr 18.
5
Treatment with coartem (artemether-lumefantrine) in Papua New Guinea.在巴布亚新几内亚使用科泰梅(青蒿琥酯-苯芴醇)进行治疗。
Am J Trop Med Hyg. 2010 Apr;82(4):529-34. doi: 10.4269/ajtmh.2010.09-0334.
6
Differential patterns of infection and disease with P. falciparum and P. vivax in young Papua New Guinean children.在年轻的巴布亚新几内亚儿童中,疟原虫和疟原虫的感染和疾病模式存在差异。
PLoS One. 2010 Feb 4;5(2):e9047. doi: 10.1371/journal.pone.0009047.
7
The perils of PCR: can we accurately 'correct' antimalarial trials?PCR 的风险:我们能准确“纠正”抗疟试验吗?
Trends Parasitol. 2010 Mar;26(3):119-24. doi: 10.1016/j.pt.2009.12.007. Epub 2010 Jan 18.
8
Quantifying the evolution and impact of antimalarial drug resistance: drug use, spread of resistance, and drug failure over a 12-year period in Papua New Guinea.量化抗疟药物耐药性的演变和影响:在巴布亚新几内亚的 12 年期间,药物使用、耐药性传播和药物失效。
J Infect Dis. 2010 Feb 1;201(3):435-43. doi: 10.1086/649784.
9
Comparison of Plasmodium falciparum allelic frequency distribution in different endemic settings by high-resolution genotyping.通过高分辨率基因分型比较不同流行地区恶性疟原虫等位基因频率分布。
Malar J. 2009 Oct 30;8:250. doi: 10.1186/1475-2875-8-250.
10
Submicroscopic infection in Plasmodium falciparum-endemic populations: a systematic review and meta-analysis.恶性疟原虫流行地区的亚显微感染:一项系统评价与荟萃分析。
J Infect Dis. 2009 Nov 15;200(10):1509-17. doi: 10.1086/644781.